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Abstract
The autosomal dominant Birt–Hogg–Dubé syndrome is known to be associated with skin, lung and kidney lesions. It is 
caused by heterozygous germline mutations in the folliculin gene and has a high penetrance. We report the case of a 51 year 
old woman with Birt–Hogg–Dubé syndrome who presented with a laryngeal mass. Imaging conirmed a mass centered on 
the piriform sinus and following excision histological examination conirmed the lesion was composed of polygonal cells 
with abundant eosinophilic cytoplasm consistent with a rhabdomyoma. Laryngeal rhabdomyoma is rare condition and 
has not been previously described in association with Birt–Hogg–Dubé. In patients with Birt–Hogg–Dubé syndrome who 
develop upper aerodigestive tract symptoms secondary to mass lesion an adult-type rhabdomyoma might be considered as 
a diferential, with endoscopic excision being the treatment of choice.
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Introduction
Birt–Hogg–Dubé (BHD) syndrome (MIM #135150) is a 
rare autosomal dominant condition predisposing suferers to 
develop characteristic skin lesions (ibrofolliculomas, tricho-
discoma and acrochordons), multiple lung cysts, spontane-
ous pneumothoraces and renal neoplasms [1]. In the head 
and neck region further associations with multinodular goi-
tre, parotid-gland oncocytoma, tonsillar carcinoma [1] and 
parathyroid adenoma [2] have been reported. This syndrome 
is caused by heterozygous germline mutations in the fol-
liculin gene (FLCN) located on chromosome 17p11.2 [1]. 
The functions of this gene are largely unknown but there 
is evidence to support a role as a tumour suppressor [1, 3].
Hamartomas such as rhabdomyomas are benign, focal 
malformations comprising of excess normal tissue grow-
ing in a disorganised fashion. A single ‘rhabdomyoma’ has 
been described among the cohort of 51 families with BHD 
syndrome, but its site was not indicated [4]. Since then, an 
adult rhabdomyoma in a presumed parathyroid adenoma and 
a cardiac rhabdomyoma in an infant carrying a FLCN muta-
tion have been described [5]. We report an adult laryngeal 
rhabdomyoma in a patient with BHD syndrome.
Case Report
A 51 year old female with BHD syndrome was noted to have 
a soft leshy mass in her supraglottic region during intu-
bation for an open partial nephrectomy for a renal tumour. 
This operation was uneventful and pathology conirmed 11 
chromophobe renal carcinomas (sizes ranging from 2 to 
10 mm) and a 9 mm renal cell carcinoma with hybrid chro-
mophobe—oncocytoma histology.
She was asymptomatic with regards to the mass in her 
larynx and had no cervical lymphadenopathy. BHD had 
been conirmed 3 years prior to her surgery by genetic 
testing which demonstrated a 4 bp deletion in one copy of 
her FLCN gene. She had no other signiicant past medi-
cal history. She had no irst degree relatives with con-
irmed BHD however had a brother who had been recently 
diagnosed with a renal tumour and was awaiting a partial 
nephrectomy. Flexible nasendoscopy in ENT outpatient 
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clinic demonstrated a smooth mass around the right arye-
piglottic fold and right arytenoid, obscuring the right piri-
form fossa. It was noted she had reduced movement of the 
right vocal cord.
An MRI neck with contrast delineated a 28 mm diam-
eter mass centred on the right piriform fossa and extend-
ing into the right supraglottis without associated lymphad-
enopathy (Fig. 1). Clinical and radiological features were 
suggestive of a benign nature and, consequently, transoral 
laser microsurgery was planned.
The patient underwent a microlaryngoscopy under gen-
eral anaesthetic. The mass appeared to be pedicled on the 
right aryepiglottic fold and the medial wall of the right 
piriform fossa. A 3 cm submucosal lobulated soft mass 
was excised using  Co2 laser (Sharplan) set on 4 W, contin-
uous wave in super-pulse mode under microscopic vision 
with a focal length of 400 mm. (Fig. 2). The postoperative 
period was uneventful and the patient was discharged on 
the day of the operation with improved motility of the 
right vocal cord.
Histological examination confirmed the lesion was 
completely excised with good margins. It was composed 
of polygonal cells with abundant eosinophilic cytoplasm 
(Fig. 3a, b). Some of the cells demonstrated cross stria-
tions (Fig. 3b, c arrow), but no obvious crystalline cyto-
plasmic inclusions were seen. There were no myxoid areas, 
mature skeletal muscle ibres, atypia, necrosis or mitosis. 
Desmin expression was extensive and highlighted the cross 
striations, a feature not seen in the main diferential diag-
nosis of a granular cell tumour (Fig. 3c). S100 highlighted 
a few scattered nuclei expressing this marker, as seen in 
adult rhabdomyoma (Fig. 3d). Myogenin showed patchy 
expression (Fig. 3e). Follow up has conirmed no evidence 
of recurrence on lexible nasendoscopy 18 months after 
initial resection.
Discussion
A rhabdomyoma is a form of hamartoma that may occur at 
cardiac and extracardiac sites. These may be further sub-
classiied histologically into adult and fetal types depend-
ing on the level of diferentiation [6, 7]. Adult rhabdo-
myoma show mature skeletal muscle diferentiation. The 
majority of extra-cardiac rhabdomyomas occur in the head 
and neck region (around 70%), mainly afecting the upper 
aero-digestive mucosa (pharynx, oral cavity and larynx) 
and soft tissue of the neck [6–9]. It is thought that these 
Fig. 1  MRI scans with contrast demonstrating an enhancing mass centered on the right piriform fossa a T1-weighted coronal, b T1-weighted 
sagittal, c T2-weighted axial
Fig. 2  Endoscopic photograph of laryngeal mass in the right piriform 
fossa taken at the time of surgery
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originate from the third and fourth branchial musculature 
due to its close association with the neck [9]. Deregula-
tion of the sonic hedgehog pathway has been suggested 
to be important in the pathogenesis of rhabdomyoblastic 
tumours [10]. The clinical presentation depends on the 
location with dysphagia, hoarseness or respiratory distress 
typical of aerodigestive tract involvement. Around 10% are 
asymptomatic; the median age of presentation is 60 years 
(ranging from 33 to 80 years) with a male predilection 
(3:1 ratio) [6, 7]. Our patient was a 51 years old female 
and given the rarity of extra-cardiac rhabdomyomas, a 
comparison of prevalence to those without this syndrome 
would be of little clinical value.
Fig. 3  a Rhabdomyoma composed of polygonal cells with abundant 
eosinophilic cytoplasm, bland nuclei and scanty nucleation. Haema-
toxylin and Eosin ×200. b Rhabdomyoma with cells demonstrating 
cross striations (arrow). Haematoxylin and Eosin ×400. c Rhabdomy-
oma, with immunohistochemistry conirming expression of desmin 
with evidence of cross striations (arrow) ×400. d Rhabdomyoma, 
with a few scattered nuclei expressing S100 × 100. e Rhabdomyoma 
showing patchy expression of myogenin ×200. f Rhabdomyoma 
stained for MyoD1 expression ×400
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Macroscopically adult rhabdomyomas are a deep tan to 
red-brown mass growing as a solitary (70%) or multinodu-
lar lesion (26%) with discrete nodules. Rarely, they may be 
multicentric (4%) [6, 7]. The histological diferential diag-
noses include granular cell tumours, hibernomas, oncocy-
tomas and paragangliomas. Immunohistochemical staining 
is helpful in distinguishing between these diagnoses. Adult 
rhabdomyoma staining will characteristically conirm skel-
etal muscle diferentiation, with tumours positive for myo-
globin, desmin and muscle-speciic actin [11, 12]. S-100 
expression, when present, is weak and focal [13]. Complete 
surgical excision is recommended because local recurrence 
is related to incomplete clearance [6, 7, 9].
A ‘rhabdomyoma’ has been described among the cohort 
of 51 families with BHD syndrome assessed by Toro et al. 
[4], but its site was not indicated. Since then, there have 
been few reports of AR with BHD syndrome. One case of 
AR in a parathyroid adenoma has been described in a patient 
undergoing thyroidectomy and parathyroidectomy for toxic 
multinodular goitre and primary hyperparathyroidism [14]. 
Cardiac rhabdomyomas have been described in the Nihon 
rat model of BHD [15]. Though rhabdomyomas have been 
described in association with BHD, there has not been a 
report in the English literature of a laryngeal lesion associ-
ated with the condition.
Tuberous sclerosis (TSC) is a tumour suppressor gene 
syndrome and its clinical similarities to that of BHD sug-
gest that the FLCN and TSC proteins may function in a 
common cellular pathway [16]. Cardiac rhabdomyomas 
in patients with TSC are linked to aberrant mTOR signal-
ling [17] through the loss of regulation by the hamartin 
(TSC1) and tuberin (TSC2) complex. Though the function 
of tumour-suppressor protein folliculin (FLCN) is still being 
conirmed, the identiication of the FLCN-interacting pro-
tein, FNIP1 has generated much interest and could explain 
the association with rhabdomyomas. FNIP1 interacts with 
5ƍAMP-activated protein kinase (AMPK), a key molecule for 
energy sensing that negatively regulates mTOR activity, sug-
gesting that FLCN may be regulated by mTOR and AMPK 
signaling [1, 17]. This has lead Bondavalli et al. to raise the 
possibility that mutations in FLCN might be the cause of 
cardiac rhabdomyomas and argue for BHD to be included in 
the diferential diagnosis of these hamartomas [5].
Expression of FLCN mRNA has been demonstrated 
widely, but not universally, in a variety of tissues with 
expression limited to certain cell types. This selective 
expression suggests the gene may be involved in particu-
lar cell processes [1, 3]. Warren et al. performed a study 
which looked at the level of FLCN expression in these tis-
sues. Although the larynx was not mentioned in this study 
other tissues including tonsils, lymph nodes, bladder, myo-
metrium, pancreas and parotid gland showed the mRNA 
expression [3]. The inding of an adult rhabdomyoma within 
the piriform fossa also raises questions as to the role of fol-
liculin in the hypopharynx.
Conclusion
It is possible that the presence of FLCN mutations in patients 
with hamartomas is more common than is widely known but 
the limited awareness of BHD is resulting in cases going 
unrecognised. The few reports describing an association 
between AR and BHD, whilst insuicient evidence for a 
causal link between the two conditions, point towards a pre-
disposition to hamartoma formation associated with hap-
loinsuiciency of FLCN. Amongst patients with BHD, an 
adult-type rhabdomyoma might be considered in the difer-
ential diagnosis when a mass lesion arises in an unexpected 
site such as the upper aerodigestive tract. Should treatment 
of an upper aerodigestive tract rhabdomyoma be required 
endoscopic excision should be the intervention of choice.
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